These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 15513439)

  • 21. Photodynamic therapy in adult-onset vitelliform macular dystrophy misdiagnosed as choroidal neovascularization.
    Menchini U; Giacomelli G; Cappelli S; Giansanti F; Romani A; Virgili G
    Arch Ophthalmol; 2002 Dec; 120(12):1761-3. PubMed ID: 12470159
    [No Abstract]   [Full Text] [Related]  

  • 22. Verteporfin in Photodynamic Therapy (VIP) Study group.
    Ruiz-Oliva F; Cortés J
    Ophthalmology; 2002 Jun; 109(6):1043; author reply 1043-4. PubMed ID: 12045040
    [No Abstract]   [Full Text] [Related]  

  • 23. Verteporfin photodynamic therapy involving the optic nerve for peripapillary choroidal neovascularization.
    Bernstein PS; Horn RS
    Retina; 2008 Jan; 28(1):81-4. PubMed ID: 18185142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photodynamic therapy with verteporfin: a new treatment in ophthalmology.
    Michels S; Schmidt-Erfurth U
    Semin Ophthalmol; 2001 Dec; 16(4):201-6. PubMed ID: 15513441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.
    Bressler NM;
    Arch Ophthalmol; 2001 Feb; 119(2):198-207. PubMed ID: 11176980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy with verteporfin for subfoveal choroidal neovascular membranes in highly myopic eyes after laser in situ keratomileusis.
    Arevalo JF; Ruiz-Moreno JM; Fernandez CF; Mendoza AJ; Ramirez E; Montero JA
    Ophthalmic Surg Lasers Imaging; 2004; 35(1):58-62. PubMed ID: 14750766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series.
    Chan WM; Lam DS; Wong TH; Lai TY; Kwok AK; Tam BS; Li KK
    Ophthalmology; 2003 Dec; 110(12):2395-402. PubMed ID: 14644724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Verteporfin in Photodynamic Therapy: report no. 5.
    Bandello F; Blinder K; Bressler NM; Brown AL; Miller JW; Potter MJ; Pournaras C; Reaves A; Rosenfeld PJ; Slakter JS; Soubrane G; Strong HA; Stur M;
    Ophthalmology; 2004 Nov; 111(11):2144. PubMed ID: 15522385
    [No Abstract]   [Full Text] [Related]  

  • 30. Choroidal neovascularization after central retinal vein occlusion in a 47-year-old man.
    DiLoreto DA; Goldberg MF; Bressler NM
    Arch Ophthalmol; 2004 Sep; 122(9):1398-401. PubMed ID: 15364727
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization.
    Eandi CM; Ober MD; Freund KB; Slakter JS; Yannuzzi LA
    Retina; 2007 Sep; 27(7):825-31. PubMed ID: 17891004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Choroidal neovascularization from a presumed subretinal nematode.
    Chen FK; Kennedy C
    Arch Ophthalmol; 2007 Sep; 125(9):1298-9. PubMed ID: 17846381
    [No Abstract]   [Full Text] [Related]  

  • 33. Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.
    Dhalla MS; Shah GK; Blinder KJ; Ryan EH; Mittra RA; Tewari A
    Retina; 2006; 26(9):988-93. PubMed ID: 17151484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.
    Degenring RF; Jonas JB
    Acta Ophthalmol Scand; 2005 Oct; 83(5):621. PubMed ID: 16188006
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of early retreatment with the standard regimen in verteporfin therapy of neovascular age-related macular degeneration.
    Michels S; Wachtlin J; Gamulescu MA; Heimann H; Prünte C; Inhoffen W; Krebs I; Schmidt-Erfurth U
    Ophthalmology; 2005 Dec; 112(12):2070-5. PubMed ID: 16225928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy in young patients with choroidal neovascularization following traumatic choroidal rupture.
    Harissi-Dagher M; Sebag M; Gauthier D; Marcil G; Labelle P; Arbour JD
    Am J Ophthalmol; 2005 Apr; 139(4):726-8. PubMed ID: 15808180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.
    Azab M; Boyer DS; Bressler NM; Bressler SB; Cihelkova I; Hao Y; Immonen I; Lim JI; Menchini U; Naor J; Potter MJ; Reaves A; Rosenfeld PJ; Slakter JS; Soucek P; Strong HA; Wenkstern A; Su XY; Yang YC;
    Arch Ophthalmol; 2005 Apr; 123(4):448-57. PubMed ID: 15824216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Verteporfin photodynamic therapy in the UK: implications of the NICE appraisal.
    Harding S
    Eye (Lond); 2003 Mar; 17(2):119-22. PubMed ID: 12640394
    [No Abstract]   [Full Text] [Related]  

  • 39. Photodynamic therapy with verteporfin (Visudyne): impact on ophthalmology and visual sciences.
    Bressler NM; Bressler SB
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):624-8. PubMed ID: 10711673
    [No Abstract]   [Full Text] [Related]  

  • 40. Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Am J Ophthalmol; 2006 Apr; 141(4):638-45. PubMed ID: 16564797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.